← Back to Search

Community-Based Health Program for Healthy Aging (EMBOLDEN Trial)

N/A

Recruiting

Led By Rebecca Ganann, PhD

Research Sponsored by McMaster University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Must not have

Unable to walk 10 meters without physical assistance from another person (assistive devices permitted)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up between baseline and 3-months. an additional comparison will be made at 6-months to examine whether potential changes are maintained in the post-intervention phase.

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing a new program to help adults over 55 years old stay active and socially connected, in order to maintain their independence and quality of life.

Who is the study for?

This trial is for community-dwelling adults aged 55 and older who live in specific neighborhoods chosen for the study. It aims to help those with limited mobility or health disparities improve their quality of life through a program that encourages physical activity, healthy eating, and social involvement.

What is being tested?

The EMBOLDEN study tests a 3-month community-based intervention designed to enhance physical activity, promote healthy eating habits, foster social participation, and assist in navigating health systems among older adults.

What are the potential side effects?

Since this is not a drug trial but an intervention involving lifestyle changes like exercise and diet modification, there are no direct side effects as one would expect from medication. However, participants may experience fatigue or muscle soreness due to increased physical activity.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I need help from someone else to walk 10 meters, but I can use a device.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ between baseline and 3-months. an additional comparison will be made at 6-months to examine whether potential changes are maintained in the post-intervention phase.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~between baseline and 3-months. an additional comparison will be made at 6-months to examine whether potential changes are maintained in the post-intervention phase.

This trial's timeline: 3 weeks for screening, Varies for treatment, and between baseline and 3-months. an additional comparison will be made at 6-months to examine whether potential changes are maintained in the post-intervention phase. for reporting.